Aristeia Capital LLC

SEC CIK: 0001080171
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ENGNW holding history

enGene Therapeutics Inc. in every 13F filed by Aristeia Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENGNW overview All 13F holders of ENGNW Full Q2 2026 holdings

Shares (Q2 2026): 197,678
Value: $47.7K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2023

Holdings of ENGNW by Aristeia Capital LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	197,678	$47.7K	<0.1%	+33,167+20.2%	Added	Holders
Q1 2026	164,511	$445.0K	<0.1%	+164,511	New	Holders
Q1 2024	0	$0	0.0%	−24,045−100.0%	Sold out	Holders
Q4 2023	24,045	$28.3K	<0.1%	+24,045	New	Holders